| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Maxim Group analyst Allen Klee downgrades Cryo-Cell International (AMEX:CCEL) from Buy to Hold.
Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate ...
Maxim Group analyst Allen Klee maintains Cryo-Cell International (AMEX:CCEL) with a Buy and lowers the price target from $9 ...
Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate ...
Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate ...